Charles River Laboratories International Inc. (CRL)
Charles River Laboratories International is a full service, non-clinical global drug development partner. Co. has laboratory animal medicine and science (research model technologies) to develop a portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, that supports its clients from target identification through non-clinical development. Co. also provides a suite of products and services to support its clients' manufacturing activities, including its contract development and manufacturing organization business. Co. has three reporting segments: Research Models and Services, Discovery and Safety Assessment and Manufacturing Solutions.
CRL SEC Filing Email Alerts Service
| Company Name: |
Charles River Laboratories International Inc. |
| Website: |
www.criver.com |
| Sector: |
Biotechnology |
| Number of ETFs Holding CRL: |
82 |
| Total Market Value Held by ETFs: |
$1.86B |
| Total Market Capitalization: |
$11.81B |
| % of Market Cap. Held by ETFs: |
15.73% |
|
|
April 20, 2024 • 7:58 AM Eastern
Buy (3.20 out of 4)
100th percentile
|
|
Free CRL Email Alerts:
